8.3 ICU Delirium, Cognitive Dysfunction & Behavioral Emergencies
Key Takeaways
ICU delirium is acute brain dysfunction associated with mortality, prolonged ventilation and persistent cognitive impairment. Cognitive deficits may remain months after critical illness; a test-score comparison with dementia does not establish a permanent neurodegenerative diagnosis.
Hypoactive delirium often presents with lethargy and psychomotor slowing. It can be mistaken for fatigue or sedation, so screen regularly for fluctuating attention and arousal.
The Confusion Assessment Method for the ICU (CAM-ICU) requires an acute change or fluctuating course (Feature 1), inattention (Feature 2), and either an altered level of consciousness (Feature 3, RASS other than 0) or disorganized thinking (Feature 4).
The evidence-based ABCDEF liberation bundle serves as the cornerstone of delirium prevention and resolution, emphasizing analgesia-first sedation, spontaneous awakening and breathing trials (SAT/SBT), non-benzodiazepine sedatives (dexmedetomidine, propofol), and early progressive mobilization.
Routine pharmacologic delirium prophylaxis with antipsychotics is not recommended by clinical guidelines; symptomatic treatment of refractory agitation or distress requires careful baseline and serial QTc interval monitoring, with discontinuation indicated if QTc exceeds 500 ms.
8.3 ICU Delirium, Cognitive Dysfunction & Behavioral Emergencies
Clinical Scenario: A 71-year-old male on post-operative day 3 following emergent repair of a ruptured abdominal aortic aneurysm remains in the surgical ICU. The nurse reports that the patient is 'unusually calm and cooperative,' sleeping between checks and taking 15 seconds to answer questions with slow, one-word responses. Vital signs: BP 128/72 mmHg, HR 68 bpm, RR 14 breaths/min, and SpO2 96% on 2 L/min nasal cannula. RASS score is . On examination, he makes five errors (missed 'A' responses or squeezes on other letters) during the SAVEAHAART vigilance test. When asked simple cognitive questions, he answers incorrectly.
Delirium Epidemiology & Clinical Subtypes
ICU delirium is an acute, fluctuating syndrome of cognitive dysfunction characterized by altered mental status, inattention, and disorganized thinking. It affects up to 60% to 80% of mechanically ventilated and 20% to 50% of non-ventilated ICU patients:
- Outcomes: Longer delirium is associated with worse outcomes, including persistent cognitive impairment.
- ICU Stay: Associated with prolonged mechanical ventilation and high institutionalization rates.
- Long-Term Cognitive Impairment: In BRAIN-ICU at 12 months, about one-third scored comparably to moderate TBI and one-quarter to mild Alzheimer disease. These cognitive-test comparisons do not diagnose neurodegenerative dementia.
| Delirium Subtype | Manifestations | Diagnostic Pitfalls |
|---|---|---|
| Hypoactive | Lethargy, slowed movement and reduced interaction | May resemble fatigue or sedation |
| Hyperactive | Restlessness, agitation, hallucinations or pulling at devices | Treat reversible causes before escalating sedation or restraint |
| Mixed | Fluctuates between hypoactive and hyperactive features | A single bedside exam can miss the fluctuation |
Validated Bedside Diagnostics: RASS & CAM-ICU
PADIS recommends regular assessment with a validated tool. SCCM’s ICU Liberation Bundle suggests screening at least once per shift and with mental status changes.
Richmond Agitation-Sedation Scale (RASS)
The RASS evaluates arousal and agitation:
- (Combative) to (Restless).
- (Alert and Calm): Optimal baseline target.
- (Drowsy): Eye contact seconds after verbal stimulation.
- (Light Sedation): Eye contact seconds.
- (Moderate Sedation): Movement or eye opening to voice, but no eye contact.
- (Deep Sedation) and (Unarousable): Defer CAM-ICU and reassess when arousal improves.
Note
Assessment Gate: Proceed with CAM-ICU when RASS is or higher. Use the visual attention test when hearing or communication limits the letter test.
CAM-ICU Algorithm
- Feature 1: Acute Onset or Fluctuating Course: Change from baseline mental status or fluctuation in the past 24 hours. (If YES, proceed to Feature 2).
- Feature 2: Inattention (The Hallmark): Tested via letter vigilance (S-A-V-E-A-H-A-A-R-T); patient squeezes on 'A'.
- Errors : CAM-ICU Negative.
- Errors : Inattention confirmed; proceed to Feature 3.
- Feature 3: Altered Level of Consciousness: Current RASS score.
- If current RASS is anything other than (e.g. ): CAM-ICU is POSITIVE.
- If current RASS is : Proceed to Feature 4.
- Feature 4: Disorganized Thinking: 4 questions ('Will a stone float on water?', 'Do fish live in sea?') and 1 command ('Hold up 2 fingers').
- Errors : CAM-ICU is POSITIVE.
- Errors : CAM-ICU is Negative.
The ABCDEF Liberation Bundle
The SCCM ABCDEF bundle is an evidence-based framework reducing delirium and mortality:
| Element | Clinical Practices | Clinical Impact |
|---|---|---|
| A: Assess & Manage Pain | CPOT/BPS monitoring; analgesia-first sedation (IV opioids before sedatives). | Pain drives delirium; analgesia-first lowers sedative exposure. |
| B: Both SAT & SBT | Daily paired Spontaneous Awakening and Breathing Trials ('Wake Up and Breathe'). | Supports earlier ventilator liberation and reduces unnecessary sedation. |
| C: Choice of Sedation | Target light sedation (RASS to ); prefer Dexmedetomidine or Propofol. | Benzodiazepine avoidance directly decreases delirium. |
| D: Delirium: Assess & Manage | Screen every shift with CAM-ICU/ICDSC; identify triggers using THINK mnemonic. | Detects hypoactive delirium; prevents restraint escalation. |
| E: Early Mobility | Progressive protocol from passive ROM to ambulation while ventilated. | Helps preserve mobility and function. |
| F: Family Engagement | Family presence on rounds, reorientation cues, and familiar voices. | Reduces anxiety; decreases acute agitation. |
Environmental & Non-Pharmacologic Strategies
Use multicomponent non-pharmacologic prevention; routine antipsychotic prophylaxis is not recommended. The 2025 PADIS update conditionally suggests melatonin, with low-certainty evidence:
- Circadian Restoration: Provide daylight cues, reduce light and avoid unnecessary noise at night, and cluster nonurgent care when feasible.
- Sensory Optimization: Provide eyeglasses, hearing aids, and dentures promptly.
- Cognitive Reorientation: Clocks, whiteboards with names/dates, and frequent verbal reorientation.
- Early Device Removal: Promptly remove restraints, urinary catheters, and central lines.
Pharmacologic Considerations & Safety Parameters
Benzodiazepine Harm
Benzodiazepine exposure is a modifiable delirium risk. Minimize avoidable use while treating specific indications such as alcohol or sedative withdrawal and status epilepticus.
Targeted Antipsychotics & QTc Surveillance
The 2025 PADIS update could not recommend for or against antipsychotics for delirium treatment. MIND-USA found no improvement in delirium/coma-free days; AID-ICU found no significant improvement in days alive/out of hospital at 90 days, although secondary 90-day mortality favored haloperidol. These results do not justify routine prophylaxis.
- Indications: Reserved strictly for severe, distressing hallucinations or agitation threatening patient safety (unplanned extubation).
- Agents: Quetiapine (25–50 mg PO q12h; aids sleep), Olanzapine (2.5–10 mg PO/IM daily; low EPS risk), and Haloperidol (0.5–2.5 mg IV/IM q4–6h PRN).
Warning
QTc Prolongation Surveillance: Antipsychotics block hERG potassium channels, delaying repolarization. Obtain baseline ECG, monitor serial QTc, and maintain and . Immediately discontinue antipsychotics if QTc exceeds (or increases over baseline) due to the risk of Torsades de Pointes.
Suicidal Ideation and Immediate Safety
A positive suicide screen requires a direct, private safety assessment of current thoughts, plan, intent, access to means, prior attempts and protective supports. Ask plainly; a calm appearance does not exclude risk. Current suicidal thoughts on adult inpatient assessment require immediate safety precautions, removal of dangerous items, continuous observation and urgent mental-health evaluation; do not leave the patient alone. A nonacute positive screen still needs assessment and a disposition plan, but does not automatically require identical precautions. Collaborate on a written safety plan, warning signs, coping strategies, support contacts and restriction of lethal means. A promise or “no-suicide contract” is not a substitute for assessment or protection.
Behavioral Emergencies, De-escalation & Restraints
- Verbal De-escalation: Calm posture, simple sentences, validating distress.
- Search for Reversible Drivers (THINK): Toxic drugs/withdrawal, Hypoxemia/hypercapnia, Infection/immobilization, Non-pharmacologic needs (retention, pain), K+/electrolytes.
- Restraints as Last Resort: Use the least restrictive effective measure and stop as soon as safe; never order PRN. For violent/self-destructive behavior, federal adult orders last at most four hours, with a one-hour face-to-face evaluation; after 24 hours, the responsible physician or authorized licensed practitioner must see and assess the patient before a new order. Nonviolent renewal and monitoring intervals follow hospital policy. Apply stricter state requirements and document reassessment, circulation, skin, respiratory safety and basic needs.
An acute care nurse practitioner is evaluating a 68-year-old intubated patient in the medical intensive care unit following septic shock secondary to pneumonia. Before this illness he was alert at baseline. After holding sedation for a spontaneous awakening trial, the team documented fluctuating attention and arousal. The patient currently opens his eyes to verbal address, makes eye contact for 12 seconds, and then closes his eyes (RASS score -1). On the SAVEAHAART letter vigilance assessment, the patient makes 4 errors (squeezing on 'E' and 'R', and missing two 'A's). When asked 4 simple cognitive questions, the patient nods accurately to all 4 questions and holds up two fingers when commanded. How should the nurse practitioner interpret this CAM-ICU assessment?
The patient is CAM-ICU positive for delirium because Features 1, 2, and 3 are present
The patient is CAM-ICU negative because the patient answered all disorganized thinking questions correctly
The patient cannot be assessed for delirium because the RASS score is negative
The patient has subsyndromal delirium requiring initiation of intravenous haloperidol
A 74-year-old female admitted to the cardiothoracic ICU on post-operative day 2 following coronary artery bypass graft surgery develops acute agitation, disorientation, and attempts to climb out of bed. Review of her medication administration record reveals she is receiving scheduled intravenous lorazepam 1 mg every 6 hours for anxiety, alongside continuous fentanyl for sternotomy pain. What is the most appropriate evidence-based pharmacological management strategy for this patient's delirium?
Increase the intravenous lorazepam dose to 2 mg every 4 hours to suppress acute hyperactive behavior
Initiate scheduled intravenous haloperidol 5 mg every 6 hours as prophylaxis against persistent delirium
Discontinue intravenous lorazepam, optimize non-opioid multimodal analgesia, and consider an infusion of dexmedetomidine if sedation is required
Initiate continuous intravenous midazolam titrated to deep sedation (RASS -4) for 48 hours to allow neurological rest
A 69-year-old male with septic shock and hyperactive delirium in the ICU is started on intravenous haloperidol 2.5 mg every 6 hours alongside oral quetiapine 50 mg at bedtime for severe combative behavior and hallucinations. During multidisciplinary rounds on day 3, the telemetry monitor displays sinus rhythm at 78 bpm with a corrected QT interval (QTc) of 530 ms (baseline QTc was 435 ms). Serum potassium is 3.5 mEq/L and serum magnesium is 1.6 mg/dL. What is the most urgent clinical action required by the acute care nurse practitioner?
Administer a 12-lead ECG and continue the antipsychotic medications with telemetric monitoring
Switch haloperidol to intravenous ziprasidone and administer 1 ampule of calcium gluconate
Increase the quetiapine dose while discontinuing haloperidol, and recheck electrolytes in 24 hours
Discontinue all antipsychotic medications immediately, aggressively replete potassium to >= 4.0 mEq/L and magnesium to >= 2.0 mg/dL, and institute non-pharmacologic calming measures
Sections you finish are checked off in the contents.